Acutus Medical Inc

Finanzen von Acutus Medical Inc (AFIB)

Umsatzquellen von AFIB

Acutus Medical Inc (AFIB) generates its revenue primarily from Disposables, which accounts for 100.0% of total sales, equivalent to $4.13M. Understanding this concentration is critical for investors evaluating how AFIB navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Profitabilität und Margen von AFIB

Evaluating the bottom line, Acutus Medical Inc maintains a gross margin of 7.06%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -36.95%, while the net margin is -15.50%. These profitability ratios, combined with a Return on Equity (ROE) of -49.22%, provide a clear picture of how effectively AFIB converts its operational activities into shareholder value.

Financials

FY2024Q3
YoY:
+0.53%
5.27M
Total Revenue
FY2024Q3
YoY:
-87.51%
-1.95M
Operating Profit
FY2024Q3
YoY:
-93.84%
-816.00K
Net Income after Tax
FY2024Q3
YoY:
-57.78%
-0.19
EPS - Diluted
FY2024Q3
YoY:
-74.32%
-3.70M
Free Cash Flow
FY2024Q3
YoY:
-111.02%
7.06
Gross Profit Margin - %
FY2024Q3
YoY:
-63.69%
-743.61
FCF Margin - %
FY2024Q3
YoY:
-93.87%
-15.50
Net Margin - %
FY2022Q4
-26.58
ROIC

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten